Homepage
Medication Guide
What are the indications for Opicapone (Ongentys)?
Opicapone (Ongentys) is an oral capsule preparation, which was first approved for marketing in the United States in 2020. As a selective and reversible peripheral catechol-O-methyltransferase (COMT) i...
511
Friday, January 23rd, 2026, 11:18
Dosage and Administration, Recommended Dosage of Opicapone (Ongentys)
Opicapone (Ongentys) is a novel, highly selective and reversible peripheral catechol-O-methyltransferase (COMT) inhibitor, which was approved for marketing in the United States in 2020.Dosage and Admi...
515
Friday, January 23rd, 2026, 11:16
Dosage and Administration of Cenobamat: Recommended Dosage
Cenobamat is a prescription medication indicated for the treatment of focal-onset seizures in adult patients. Proper administration of this drug is crucial to ensure therapeutic efficacy and minimize ...
511
Friday, January 23rd, 2026, 10:45
What Are the Indications for Cenobamat?
Cenobamat is an oral antiepileptic drug primarily indicated for the treatment of partial-onset seizures in adults. First approved in the United States in 2019, it is classified as a novel antiepilepti...
509
Thursday, January 22nd, 2026, 10:02
What Are the Purchase Channels for Cenobamat?
Cenobamat is a novel antiepileptic drug indicated for the treatment of partial-onset seizures in adults. Owing to its remarkable efficacy, an increasing number of patients and their families have begu...
510
Thursday, January 22nd, 2026, 09:58
Dosage and Administration of Dalfampridine Extended-Release Tablets (Fampyra)
Dalfampridine Extended-Release Tablets (Fampyra) are a potassium channel blocker indicated to improve walking ability in adult patients with multiple sclerosis (MS).Dosage and Administration of Dalfam...
525
Thursday, January 22nd, 2026, 09:54
What Are the Indications for Dalfampridine Extended-Release Tablets (Fampyra)?
Dalfampridine Extended-Release Tablets (Fampyra) is a prescription medication developed by Acorda Therapeutics, which was first approved for marketing in the United States in 2010. A potassium channel...
512
Thursday, January 22nd, 2026, 09:52
What Are the Purchase Channels for Fampridine Sustained-Release Tablets (Fampyra)?
Fampridine Sustained-Release Tablets (Fampyra) is a prescription medication indicated for improving walking ability in patients with multiple sclerosis (MS). Patients are most concerned about its purc...
511
Wednesday, January 21st, 2026, 09:23
Adverse Reactions of Encorafenib (Braftovi)
Encorafenib (Braftovi) is a kinase inhibitor targeting BRAFV600E or V600K mutations, indicated for the treatment of specific types of melanoma, colorectal cancer, and non-small cell lung cancer. While...
513
Wednesday, January 21st, 2026, 09:21
What Are the Precautions for Encorafenib (Braftovi) Administration?
Encorafenib (Braftovi) is a kinase inhibitor targeting BRAF V600E or V600K mutations, indicated for use in combination with drugs such as binimetinib or cetuximab for the treatment of specific types o...
515
Wednesday, January 21st, 2026, 09:19
27 / 221
2204 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved